×

Month: March 2025

Adrenal glands
In the Journal of Endocrinological Investigation, reviewers have described how aging affects the adrenal glands, which has downstream effects on the rest of the human body. Small but vital This paper begins with an in-depth description of the anatomy of the adrenal glands, which sit atop the kidneys, and the various hormones that each of...
Rejuve.ai logo
Longevity research network, Rejuve.AI, today launches Rejuve Longevity, an app that combines AI, cutting-edge research and blockchain technology to widen access to longevity treatments and advice. Rejuve Longevity analyzes users’ demographic, medical, and lifestyle data to give them a biological age estimate, alongside other personalized health insights. At its core, Rejuve Longevity is designed to...
Brain activity
Some brain regions are more vulnerable to Alzheimer’s disease than others. A new study suggests that this might be due to how they uptake cholesterol [1]. Why do some parts of the brain succumb earlier? Despite decades of research and vast amounts of funding, scientists still have limited understanding of how Alzheimer’s disease develops and...
Older man with back pain
Researchers have found a new avenue for approaching spinal disc degeneration and published their work in Aging Cell. A very common problem Back problems in the elderly are widely known to be caused by a deteriorating spine. Some of these problems are due to the vertebrae themselves losing cohesion, such as in osteoporosis, but the...
Hot day
A recent study reported significant associations between increased heat days and accelerated epigenetic aging [1]. Heat alters DNA While warm summer days on the beach are pleasant, extreme heat is not as enjoyable, especially in daily life. It is also not healthy, since extreme heat has been linked to cardiovascular diseases and death [2, 3]....
Alzheimer's disease
According to an open-label study from Washington University in St. Louis, the anti-amyloid drug gantenerumab reduced the risk of developing familial Alzheimer’s disease in a subgroup of participants [1]. Is it about amyloid beta? Despite billions of dollars invested in developing therapies against Alzheimer’s disease, the progress has been slow. The decades-old amyloid cascade hypothesis...